Definitive Healthcare's Q4 2023 performance, with adjusted EPS at $0.07, sales of $65.93 million, and a 5% Y/Y growth in enterprise clients. Get insights into Q1 2024 guidance and fiscal year 2024 expectations, despite macroeconomic challenges. Analysts note resilience and positive developments, maintaining an Outperform rating.